Related Experiment Video
Updated: Aug 11, 2026

Measuring Cardiac Autonomic Nervous System (ANS) Activity in Children
Published on: April 29, 2013
[Hereditary angioneurotic edema in children]
1Altalános Orvostudományi Kar Kútvölgyi Igazgatóság, Fül-orr-gégészeti, Allergológiai és Angiooedema Szakrendelés, Semmelweis Egyetem, Budapest.
Insights
Hereditary angioneurotic edema (HAE) is caused by C1-esterase inhibitor deficiency. Effective prophylaxis and treatment, including C1-inhibitor concentrate, significantly reduce HAE attacks and improve pediatric patients' quality of life.
Area of Science:
- Immunology
- Genetics
- Pediatrics
Context:
- Hereditary angioneurotic edema (HAE) is an autosomal dominant disorder.
- It stems from a deficiency in C1-esterase inhibitor.
- Characterized by recurrent swelling in the subcutis and submucosa.
Purpose:
- To review clinical records of 21 children with HAE.
- To evaluate the effectiveness of prophylaxis and treatment strategies.
- To assess the role of abdominal ultrasonography in HAE management.
Summary:
- Clinical manifestations typically begin between 2.5 and 12 years of age, with mechanical trauma as a common trigger.
- Long-term prophylaxis with tranexamic acid and danazol, and short-term prophylaxis were administered.
- C1-inhibitor concentrate effectively resolved acute attacks, and abdominal ultrasonography revealed transient ascites.
- Therapy improved serum complement levels and reduced attack frequency and severity.
Impact:
- Adequate prophylaxis and follow-up care can prevent edematous attacks in pediatric patients.
- Optimizing drug dosage minimizes adverse effects and enhances patient quality of life.
- This study highlights the importance of comprehensive management for HAE in children.
Abstract:
Hereditary angioneurotic edema results from the deficiency of C1-esterase inhibitor. The clinical picture of this autosomal dominant disorder is characterized by recurrent attacks of edema formation in the subcutis and/or the submucosa. The clinical records of 21 children with established hereditary angioneurotic edema were reviewed. Follow-up care included laboratory check-ups and abdominal ultrasound. Clinical manifestations of the disease first occurred in 2.5 to 12 years of age. Mechanical trauma was the most common precipitating factor. Pedigree-analysis revealed 19 patients with afflicted relatives. Long-term prophylaxis was initiated with tranexamic acid and danazol in 10 cases; 2 children required short-term prophylaxis. Therapy improved serum complement parameters significantly and reduced the frequency and severity of clinical manifestations. Acute, life-threatening edematous attacks were treated by the administration of C1-inhibitor concentrate, which achieved the resolution of the edema within several hours. Abdominal ultrasonography performed during the attack invariably demonstrated transitory ascites that resolved spontaneously after treatment. Adequate prophylaxis and follow-up care can spare pediatric patients from edematous attacks. Undesirable adverse effects can be avoided and the patient's quality of life can be enhanced considerably by administering the lowest effective drug dose.
Related Concept Videos
Allergic Reactions: Anaphylaxis
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Cerebral Edema l: Introduction
Cerebral Edema ll: Pathophysiology
Cytotoxic Edema: Pathophysiology

